← The Wire
ICLRNasdaq
ICON PLC
Services-Commercial Physical & Biological Research · CIK 1060955
ICON provides outsourced development and services to pharmaceutical, biotech, medical device, and public health organizations
⚡ Elevated coverage
$11.19B
Market cap
$172.99
Last close
+1.8%
1D
+22.9%
5D
1.4M
Volume
Price · last 39 sessions+54.5%
May 4L $111.97 · H $172.99Jun 29
562
Total filings
Jun 26, 2026
Last filing
—
Fiscal year end
SC 13GSEC SCHEDULE 13GMay 7, 2021SC 13GSEC SCHEDULE 13GFeb 10, 2017SC 13GFORM SC 13GFeb 16, 2016SC 13GICON PLC - 12/31/2011Feb 14, 2012SC 13GICON PUBLIC LIMITED COMPANYOct 7, 2011SC 13GSC 13G RE: ICON PLCFeb 17, 2009SC 13GBENEFICIAL OWNERSHIP OF 5% OR MOREFeb 14, 2006SC 13GSC 13GOct 11, 2005SC 13GSC 13GOct 11, 2005SC 13GSCHEDULE 13GMay 27, 2004SC 13GSCHEDULE 13GMay 27, 2004SC 13GSCHEDULE 13GFeb 13, 2004SC 13GDOC ONEJan 12, 2004SC 13GSC 13GDec 10, 2003SC 13GSCHEDULE 13GNov 20, 2002SC 13GSCHEDULE 13GAug 29, 2002SC 13GSCHEDULE 13GFeb 14, 2002SC 13GSCHEDULE 13GFeb 14, 2002SC 13GSC 13GFeb 12, 2001
In the News
⚡ Elevated coverageCoverage (30d): 1 reputable article.
MorningstarIcon Earnings: Strong Bookings Support Recovery, but Headwinds Hinder Near-Term Profitability5d agoForbesICON (Ireland)1mo ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance